Should pharmacists be able to provide the pill over the counter?

Healthed

writer

Healthed

Healthed

Phoebe Roth, The Conversation

As we head towards a federal election, the Labor government recently announced a funding package worth A$573 million for women’s health.

The funding includes $100 million to support two national trials for pharmacies to provide the oral contraceptive pill and treatments for uncomplicated urinary tract infections over the counter.

The question of whether or not pharmacists should be able to provide the oral contraceptive pill without a prescription from a GP has long been a topic of debate.

We asked five experts for their thoughts. Should pharmacists be able to provide the pill over the counter without a script?

Four out of five said yes. Here are their detailed responses.

The Conversation

Phoebe Roth, Health Editor, The Conversation

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant

Dr Sushil Pant

Frozen Shoulder – A Practical Guide to Assessment and Management

Dr Robert Hungerford

Dr Robert Hungerford

Implementing the Four Pillars of Heart Failure Management in GP

Prof Robert Norman

Prof Robert Norman

PCOS Update

Dr Clare Tiedeman

Dr Clare Tiedeman

Biologics in COPD – 20% of Your Patients Could Benefit

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.